Cargando…

Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis

BACKGROUND: Estimation of left ventricular filling pressures (LVFP) is a determining factor in the follow-up of patients with cardiac amyloidosis (CA). Natriuretic peptides (NPs) and tissue Doppler imaging may be used to monitor LVFP in patients with CA. The aim of this study was to evaluate the val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brun, Stéphanie, Cariou, Eve, Fournier, Pauline, Ribes, David, Faguer, Stanislas, Huart, Antoine, Carrié, Didier, Galinier, Michel, Lairez, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546193/ https://www.ncbi.nlm.nih.gov/pubmed/31217996 http://dx.doi.org/10.1136/openhrt-2018-000980

Ejemplares similares

Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?
por: Roger-Rollé, Aénora, et al.
Publicado: (2020)

Tip of the iceberg: a tertiary care centre retrospective study of left ventricular hypertrophy aetiologies
por: Beneyto, Maxime, et al.
Publicado: (2021)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
por: Agha, Ali M, et al.
Publicado: (2018)

Essential components in natriuretic peptide-guided management of heart failure: an intervention synthesis
por: Oke, Jason, et al.
Publicado: (2018)

Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis
por: Schrutka, Lore, et al.
Publicado: (2022)

Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004–2018
por: Taylor, Clare J, et al.
Publicado: (2022)

Diagnostic yield of a heart failure referral pathway using N-terminal pro-brain natriuretic peptide
por: Zegard, Abbasin, et al.
Publicado: (2023)

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
por: Law, Steven, et al.
Publicado: (2022)

Improvements of predictive power of B-type natriuretic peptide on admission by mathematically estimating its discharge levels in hospitalised patients with acute heart failure
por: Anegawa, Eiji, et al.
Publicado: (2021)

Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy
por: Aurich, Matthias, et al.
Publicado: (2023)

Prognostic significance of repeated brain natriuretic peptide measurements after percutaneous transluminal septal myocardial ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy
por: Akita, Keitaro, et al.
Publicado: (2018)

A COMBINED APPROACH USING HIGH-SENSITIVE TROPONIN I AND N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE FOR RISK STRATIFICATION IN PATIENTS WITH CORONAVIRUS DISEASE 2019
por: Sano, Madoka, et al.
Publicado: (2023)

Prognostic value of left ventricular mitral annular longitudinal displacement obtained by tissue Doppler imaging in patients with heart failure with reduced ejection fraction
por: Sengeløv, Morten, et al.
Publicado: (2021)

Gateway and journey of patients with cardiac amyloidosis
por: Dang, Daniel, et al.
Publicado: (2020)

Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis
por: Prameswari, Hawani Sasmaya, et al.
Publicado: (2023)

Aetiological and morphological spectrum of cardiomyopathies in French Guiana: a retrospective study
por: Leménager, Paul, et al.
Publicado: (2020)

Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
por: Salazar-Mendiguchía, Joel, et al.
Publicado: (2020)

Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates
por: Janoušek, J, et al.
Publicado: (2009)

Prospective development and validation of a model to predict heart failure hospitalisation
por: Cubbon, R M, et al.
Publicado: (2014)

Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
por: Medenwald, D, et al.
Publicado: (2014)

Endothelial function and left ventricular diastolic functional reserve in type 2 diabetes mellitus
por: Leung, Melissa, et al.
Publicado: (2014)

Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
por: Lampropulos, Julianna F, et al.
Publicado: (2014)

Vitamin D levels and left ventricular diastolic function
por: Pandit, Anil, et al.
Publicado: (2014)

Novel cardiac pacemaker-based human model of periodic breathing to develop real-time, pre-emptive technology for carbon dioxide stabilisation
por: Baruah, Resham, et al.
Publicado: (2014)

Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR
por: Suwa, Kenichiro, et al.
Publicado: (2014)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia: a multicentre cross-sectional cohort study
por: Chow, V, et al.
Publicado: (2014)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
por: Critoph, Christopher Howell, et al.
Publicado: (2014)

In-hospital treatment and outcomes of heart failure in specialist and non-specialist services: a retrospective cohort study in the elderly
por: Parmar, Kishan R, et al.
Publicado: (2015)

Predictors and prognostic value of left atrial remodelling after acute myocardial infarction
por: Kyhl, Kasper, et al.
Publicado: (2015)

Left ventricular diastolic reserve in patients with type 2 diabetes mellitus
por: Leung, Melissa, et al.
Publicado: (2015)

Clinical prediction of incident heart failure risk: a systematic review and meta-analysis
por: Yang, Hong, et al.
Publicado: (2015)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy
por: Tateishi, Emi, et al.
Publicado: (2015)

The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD
por: Buchan, Alice, et al.
Publicado: (2015)

Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction
por: Mentz, Robert J, et al.
Publicado: (2015)

Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery
por: Prior, David L, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v4eei0pl05cpsgkc2d3t8bt5s7